{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T12:13:53Z","timestamp":1779884033187,"version":"3.53.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Key R&D Program of China","award":["2017YFC1307500"],"award-info":[{"award-number":["2017YFC1307500"]}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81571107"],"award-info":[{"award-number":["81571107"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81771137"],"award-info":[{"award-number":["81771137"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81971103"],"award-info":[{"award-number":["81971103"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81901077"],"award-info":[{"award-number":["81901077"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Scientific and Technical Project of Guangdong Province","award":["2019A030317006"],"award-info":[{"award-number":["2019A030317006"]}]},{"name":"Sun Yat-sen University Clinical Research 5010 Program","award":["2018001"],"award-info":[{"award-number":["2018001"]}]},{"name":"the Southern China International Cooperation Base for Early Intervention and Functional Rehabilitation of Neurological Diseases","award":["2015B050501003"],"award-info":[{"award-number":["2015B050501003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s40256-020-00460-8","type":"journal-article","created":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T04:22:46Z","timestamp":1607919766000},"page":"377-382","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Aspirin Therapy in Cardiovascular Disease with Glucose-6-Phosphate Dehydrogenase Deficiency, Safe or Not?"],"prefix":"10.1007","volume":"21","author":[{"given":"Jianle","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yicong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilin","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fubing","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zimu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiating","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4280-0439","authenticated-orcid":false,"given":"Jinsheng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,14]]},"reference":[{"key":"460_CR1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(08)60073-2","volume":"371","author":"MD Cappellini","year":"2008","unstructured":"Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008;371:64\u201374.","journal-title":"Lancet"},{"key":"460_CR2","first-page":"1277","volume":"72","author":"JE Frank","year":"2005","unstructured":"Frank JE. Diagnosis and management of G6PD deficiency. Am Fam Physician. 2005;72:1277\u201382.","journal-title":"Am Fam Physician"},{"key":"460_CR3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.hoc.2015.11.006","volume":"30","author":"L Luzzatto","year":"2016","unstructured":"Luzzatto L, Nannelli C, Notaro R. Glucose-6-phosphate dehydrogenase deficiency. Hematol Oncol Clin N Am. 2016;30:373\u201393.","journal-title":"Hematol Oncol Clin N Am"},{"key":"460_CR4","doi-asserted-by":"crossref","first-page":"817","DOI":"10.7326\/0003-4819-64-4-817","volume":"64","author":"ER Burka","year":"1966","unstructured":"Burka ER, Weaver Z 3rd, Marks PA. Clinical spectrum of hemolytic anemia associated with glucose-6-phosphate dehydrogenase deficiency. Ann Intern Med. 1966;64:817\u201325.","journal-title":"Ann Intern Med"},{"key":"460_CR5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/bmj.288.6412.179","volume":"288","author":"O Shalev","year":"1984","unstructured":"Shalev O, Wollner A, Menczel J. Diabetic ketoacidosis does not precipitate haemolysis in patients with the Mediterranean variant of glucose-6-phosphate dehydrogenase deficiency. Br Med J (Clin Res Ed). 1984;288:179\u201380.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"460_CR6","doi-asserted-by":"crossref","first-page":"8060193","DOI":"10.1155\/2019\/8060193","volume":"2019","author":"K Georgakouli","year":"2019","unstructured":"Georgakouli K, Fatouros IG, Draganidis D, et al. Exercise in glucose-6-phosphate dehydrogenase deficiency: harmful or harmless? A narrative review. Oxid Med Cell Longev. 2019;2019:8060193.","journal-title":"Oxid Med Cell Longev"},{"key":"460_CR7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000206201","volume":"23","author":"A Szeinberg","year":"1960","unstructured":"Szeinberg A, Kellermann J, Adam A, et al. Haemolytic jaundice following aspirin administration to a patient with a deficiency of glucose-6-phosphate dehydrogenase in erythrocytes. Acta Haematol. 1960;23:58\u201364.","journal-title":"Acta Haematol"},{"key":"460_CR8","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000205562","volume":"81","author":"T Meloni","year":"1989","unstructured":"Meloni T, Forteleoni G, Ogana A, et al. Aspirin-induced acute haemolytic anaemia in glucose-6-phosphate dehydrogenase-deficient children with systemic arthritis. Acta Haematol. 1989;81:208\u20139.","journal-title":"Acta Haematol"},{"key":"460_CR9","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1177\/106002809102501010","volume":"25","author":"O Shalev","year":"1991","unstructured":"Shalev O. Long-term, low-dose aspirin is safe in glucose-6-phosphate dehydrogenase deficiency. DICP. 1991;25:1074\u20135.","journal-title":"DICP"},{"key":"460_CR10","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/(SICI)1096-8652(199602)51:2<174::AID-AJH18>3.0.CO;2-I","volume":"51","author":"DH Lee","year":"1996","unstructured":"Lee DH, Warkentin TE, Neame PB, et al. Acute hemolytic anemia precipitated by myocardial infarction and pericardial tamponade in G6PD deficiency. Am J Hematol. 1996;51:174\u20135.","journal-title":"Am J Hematol"},{"key":"460_CR11","first-page":"601","volume":"67","author":"WHO Working Group","year":"1989","unstructured":"WHO Working Group. Glucose-6-phosphate dehydrogenase deficiency. Bull World Health Organ. 1989;67:601\u201311.","journal-title":"Bull World Health Organ"},{"key":"460_CR12","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1001\/jama.297.18.2018","volume":"297","author":"CL Campbell","year":"2007","unstructured":"Campbell CL, Smyth S, Montalescot G, et al. Aspirin dose for the prevention of cardiovascular disease: a systematic review. JAMA. 2007;297:2018\u201324.","journal-title":"JAMA"},{"key":"460_CR13","doi-asserted-by":"crossref","first-page":"144","DOI":"10.14503\/THIJ-16-6052","volume":"45","author":"JE Thomas","year":"2018","unstructured":"Thomas JE, Kang S, Wyatt CJ, et al. Glucose-6-phosphate dehydrogenase deficiency is associated with cardiovascular disease in U.S. military centers. Tex Heart Inst J. 2018;45:144\u201350.","journal-title":"Tex Heart Inst J"},{"issue":"11","key":"460_CR14","doi-asserted-by":"crossref","first-page":"e1471","DOI":"10.1212\/WNL.0000000000010245","volume":"95","author":"Z Ou","year":"2020","unstructured":"Ou Z, Chen Y, Li J, et al. Glucose-6-phosphate dehydrogenase deficiency and stroke outcomes. Neurology. 2020;95(11):e1471\u20138.","journal-title":"Neurology"},{"key":"460_CR15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.atherosclerosis.2019.01.027","volume":"282","author":"GM Pes","year":"2019","unstructured":"Pes GM, Parodi G, Dore MP. Glucose-6-phosphate dehydrogenase deficiency and risk of cardiovascular disease: a propensity score-matched study. Atherosclerosis. 2019;282:148\u201353.","journal-title":"Atherosclerosis"},{"key":"460_CR16","doi-asserted-by":"publisher","DOI":"10.1177\/1747493020950903","author":"Y Chen","year":"2020","unstructured":"Chen Y, Li J, Ou Z, et al. Safety and efficacy of low-dose aspirin in ischemic stroke patients with different G6PD conditions. Int J Stroke. 2020. https:\/\/doi.org\/10.1177\/1747493020950903(Epub 2 Sep 2020).","journal-title":"Int J Stroke"},{"key":"460_CR17","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4269\/ajtmh.16-0779","volume":"97","author":"R Rueangweerayut","year":"2017","unstructured":"Rueangweerayut R, Bancone G, Harrell EJ, et al. Hemolytic potential of tafenoquine in female volunteers heterozygous for glucose-6-phosphate dehydrogenase (G6PD) deficiency (G6PD Mahidol Variant) versus G6PD-normal volunteers. Am J Trop Med Hyg. 2017;97:702\u201311.","journal-title":"Am J Trop Med Hyg"},{"key":"460_CR18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.blre.2007.05.002","volume":"21","author":"PJ Mason","year":"2007","unstructured":"Mason PJ, Bautista JM, Gilsanz F. G6PD deficiency: the genotype-phenotype association. Blood Rev. 2007;21:267\u201383.","journal-title":"Blood Rev"},{"key":"460_CR19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJM199101173240306","volume":"324","author":"E Beutler","year":"1991","unstructured":"Beutler E. Glucose-6-phosphate dehydrogenase deficiency. N Engl J Med. 1991;324:169\u201374.","journal-title":"N Engl J Med"},{"key":"460_CR20","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1056\/NEJM197604222941702","volume":"294","author":"BE Glader","year":"1976","unstructured":"Glader BE. Salicylate-induce injury of pyruvate-kinase-deficient erythrocytes. N Engl J Med. 1976;294:916\u20138.","journal-title":"N Engl J Med"},{"key":"460_CR21","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.1016\/S0021-9258(17)33098-3","volume":"251","author":"M Hemler","year":"1976","unstructured":"Hemler M, Lands WE. Purification of the cyclooxygenase that forms prostaglandins. Demonstration of two forms of iron in the holoenzyme. J Biol Chem. 1976;251:5575\u20139.","journal-title":"J Biol Chem"},{"key":"460_CR22","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMra052717","volume":"353","author":"P Carlo","year":"2005","unstructured":"Carlo P, Luis AGR, Raffaele L, et al. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med. 2005;353:2373\u201383.","journal-title":"N Engl J Med"},{"key":"460_CR23","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1172\/JCI106349","volume":"49","author":"NT Shahidi","year":"1970","unstructured":"Shahidi NT, Westring DW. Acetylsalicylic acid-induced hemolysis and its mechanism. J Clin Investig. 1970;49:1334\u201340.","journal-title":"J Clin Investig"},{"key":"460_CR24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.2042-7158.1967.tb08045.x","volume":"19","author":"MJH Smith","year":"1967","unstructured":"Smith MJH, Sturman JA. The mechanism of inhibition by salicylate of the pentose phosphate pathway in the human red cell. J Pharm Pharmacol. 1967;19:108\u201313.","journal-title":"J Pharm Pharmacol"},{"key":"460_CR25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/219068a0","volume":"219","author":"RN Pinckard","year":"1968","unstructured":"Pinckard RN, Hawkins D, Farr RS. In vitro acetylation of plasma proteins, enzymes and DNA by aspirin. Nature. 1968;219:68\u20139.","journal-title":"Nature"},{"key":"460_CR26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1172\/JCI108068","volume":"56","author":"KR Bridges","year":"1975","unstructured":"Bridges KR, Schmidt GJ, Jensen M, et al. The acetylation of hemoglobin by aspirin in vitro and in vivo. J Clin Investig. 1975;56:201\u20137.","journal-title":"J Clin Investig"},{"key":"460_CR27","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/jama.1962.03050180034008a","volume":"180","author":"R Kellermeyer","year":"1962","unstructured":"Kellermeyer R, Tarlov A, Brewer G, et al. Hemolytic effect of therapeutic drugs: clinical considerations of the primaquine-type hemolysis. JAMA. 1962;180:128\u201334.","journal-title":"JAMA"},{"key":"460_CR28","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/archinte.1966.00290160085016","volume":"118","author":"DW Westring","year":"1966","unstructured":"Westring DW, Pisciotta AV. Anemia, cataracts, and seizures in patient with glucose-6-phosphate dehydrogenase deficiency. Arch Intern Med. 1966;118:385\u201390.","journal-title":"Arch Intern Med"},{"key":"460_CR29","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/bmj.2.6046.1227","volume":"2","author":"TK Chan","year":"1976","unstructured":"Chan TK, Todd D, Tso SC. Drug-induced haemolysis in glucose-6-phosphate dehydrogenase deficiency. BMJ. 1976;2:1227\u20139.","journal-title":"BMJ"},{"key":"460_CR30","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0022-3476(76)80626-9","volume":"89","author":"BE Glader","year":"1976","unstructured":"Glader BE. Evaluation of the hemolytic role of aspirin in glucose-6-phosphate dehydrogenase deficiency. J Pediatr. 1976;89:1027\u20138.","journal-title":"J Pediatr"},{"key":"460_CR31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF02240459","volume":"3","author":"RA Seeler","year":"1982","unstructured":"Seeler RA, Luken JA. Hemolysis in a Glouse-6-phosphate dehydrogenase deficient boy with rheumatic fever. Pediatr Cardiol. 1982;3:241\u20132.","journal-title":"Pediatr Cardiol"},{"key":"460_CR32","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/BF02424982","volume":"5","author":"RA Seeler","year":"1984","unstructured":"Seeler RA, Luken JA. Hemolysis in ARF in a G6PD-deficient patient: case 2. Pediatr Cardiol. 1984;5:328\u20139.","journal-title":"Pediatr Cardiol"},{"key":"460_CR33","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/02724936.1990.11747454","volume":"10","author":"VP Choudhry","year":"1990","unstructured":"Choudhry VP, Ghafary A, Zaher M, et al. Drug-induced haemolysis and renal failure in children with glucose-6-phosphate dehydrogenase deficiency in Afghanistan. Ann Trop Paediatr. 1990;10:335\u20138.","journal-title":"Ann Trop Paediatr"},{"key":"460_CR34","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jsps.2014.11.003","volume":"23","author":"H Obeidat","year":"2015","unstructured":"Obeidat H, Al-Dossary S, Asseri A. Kawasaki disease with Glucose-6-Phosphate Dehydrogenase deficiency: case report. Saudi Pharm J. 2015;23:455\u20137.","journal-title":"Saudi Pharm J"},{"key":"460_CR35","first-page":"56","volume":"9","author":"V Khurana","year":"1998","unstructured":"Khurana V, Bradley TP. Adult-onset Still\u2019s disease associated with G6PD deficiency: a case report and literature review. J Assoc Acad Minor Phys. 1998;9:56\u20138.","journal-title":"J Assoc Acad Minor Phys"},{"key":"460_CR36","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00000441-195407000-00005","volume":"228","author":"R Read","year":"1954","unstructured":"Read R, Wilson G, Gardner F. The use of radioactive sodium chromate to evaluate the life span of the red blood cell in health and certain hematologic disorders. Am J Med Sci. 1954;228:40\u201352.","journal-title":"Am J Med Sci"},{"key":"460_CR37","first-page":"827","volume":"52","author":"RW Kellermayer","year":"1958","unstructured":"Kellermayer RW, Tarlow AR, Schrier SL, et al. Haemolytic effect of commonly uesd durgs on erythrocytes deficient in glucose-6-phosphate dehydrogenase. J Lab Clin Med. 1958;52:827.","journal-title":"J Lab Clin Med"},{"key":"460_CR38","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.2459\/JCM.0b013e32831103c3","volume":"9","author":"S Rigattieri","year":"2008","unstructured":"Rigattieri S, Silvestri P, Minucci A, et al. Drug-eluting stents in a patient with favism: is the aspirin administration safe? J Cardiovasc Med (Hagerstown). 2008;9:1159\u201362.","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"460_CR39","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ijcard.2012.08.024","volume":"165","author":"C Pappas","year":"2013","unstructured":"Pappas C, Ntai K, Parissis JT, et al. Dual anti-platelet therapy in patients with G6PD deficiency after percutaneous coronary intervention. Int J Cardiol. 2013;165:380\u20132.","journal-title":"Int J Cardiol"},{"key":"460_CR40","doi-asserted-by":"crossref","first-page":"535","DOI":"10.5551\/jat.29371","volume":"22","author":"S Biscaglia","year":"2015","unstructured":"Biscaglia S, Ferri A, Pavasini R, et al. Dual antiplatelet therapy in patients with glucose-6-phosphate dehydrogenase deficiency undergoing PCI with drug-eluting stents. J Atheroscler Thromb. 2015;22:535\u201341.","journal-title":"J Atheroscler Thromb"},{"key":"460_CR41","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/jcpt.12262","volume":"40","author":"NV Kafkas","year":"2015","unstructured":"Kafkas NV, Liakos CI, Mouzarou AG. Antiplatelet and invasive treatment in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency and acute coronary syndrome. The safety of aspirin. J Clin Pharm Ther. 2015;40:349\u201352.","journal-title":"J Clin Pharm Ther"},{"key":"460_CR42","volume":"2017","author":"J Feghaly","year":"2017","unstructured":"Feghaly J, Al Hout AR, Mercieca Balbi M. Aspirin safety in glucose-6-phosphate dehydrogenase deficiency patients with acute coronary syndrome undergoing percutaneous coronary intervention. BMJ Case Rep. 2017;2017:bcr2017220483.","journal-title":"BMJ Case Rep"},{"key":"460_CR43","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvaa060","author":"GD Sanna","year":"2020","unstructured":"Sanna GD, Deriu S, Uras M, et al. Aspirin adherence in subjects with glucose-6-phosphate-dehydrogenase deficiency having an acute coronary syndrome. Eur Heart J Cardiovasc Pharmacother. 2020. https:\/\/doi.org\/10.1093\/ehjcvp\/pvaa060 ((Epub 12 Jun 2020)).","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"460_CR44","unstructured":"First Affiliated Hospital, Sun Yat-Sen University. Safety and Efficacy of Aspirin in Stroke Patients With Glucose-6-phosphate Dehydrogenase Deficiency (SAST). ClinicalTrials.gov identifier: NCT04088513. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04088513. Accessed 11 Sept 2020."}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-020-00460-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40256-020-00460-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-020-00460-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T02:18:24Z","timestamp":1625710704000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40256-020-00460-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,14]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["460"],"URL":"https:\/\/doi.org\/10.1007\/s40256-020-00460-8","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,14]]},"assertion":[{"value":"20 November 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was supported by grants from the National Key R&D Program of China (2017YFC1307500), the Natural Science Foundation of China (81571107, 81771137, 81971103, 81901077), the Scientific and Technical Project of Guangdong Province (2019A030317006), Sun Yat-sen University Clinical Research 5010 Program (2018001), the Southern China International Cooperation Base for Early Intervention and Functional Rehabilitation of Neurological Diseases (2015B050501003), Guangdong Provincial Engineering Center for Major Neurological Disease Treatment, Guangdong Provincial Translational Medicine Innovation Platform for Diagnosis and Treatment of Major Neurological Disease, and Guangdong Provincial Clinical Research Center for Neurological Diseases.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Jianle Li, Yicong Chen, Zilin Ou, Fubing Ouyang, Jiahui Liang, Zimu Jiang, Chunyong Chen, Pingping Li, Jiaxin Chen, Jiating Wei and Jinsheng Zeng report no conflicts of interest that are relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}